Net Margin - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Net Margin
Theriva Biologics Inc

0%
Current
0%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-19m
/
Revenue
0

Net Margin Across Competitors

Country US
Market Cap 41.5m EUR
Net Margin N/A
Country US
Market Cap 340.3B USD
Net Margin
10%
Country US
Market Cap 181.1B USD
Net Margin
10%
Country US
Market Cap 129.3B USD
Net Margin
32%
Country US
Market Cap 123.8B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 104.7B USD
Net Margin
4%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.2B USD
Net Margin
-557%
Country US
Market Cap 35.7B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Theriva Biologics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-19m
/
Revenue
0
What is the Net Margin of Theriva Biologics Inc?

Based on Theriva Biologics Inc's most recent financial statements, the company has Net Margin of 0%.